ENDRA Life Sciences (NDRA) Change in Receivables (2017 - 2018)
ENDRA Life Sciences (NDRA) posted quarterly Change in Receivables of -$12275.0 for Q4 2018, down 279.2% YoY from $6850.0 in Q4 2017, and down 2530.69% sequentially from $505.0 in Q3 2018.
ENDRA Life Sciences (NDRA) Change in Receivables (2017 - 2018) Analysis & Trends
ENDRA Life Sciences has disclosed Change in Receivables across 2 years of filings, most recently posting -$12275.0 for Q4 2018.
- In Q4 2018, Change in Receivables fell 279.2% year-over-year to -$12275.0; the TTM figure through Sep 2019 stood at -$12275.0 (down 200.0% YoY), while the FY2018 annual figure was -$6850.0, down 200.0% from the prior year.
- Change in Receivables retreated to -$12275.0 in Q4 2018, from $505.0 in the prior quarter.
- Over the last five years, Change in Receivables for NDRA reached as high as $6850.0 in Q4 2017 and fell as low as -$12275.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 533.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -66.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 56.81 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 121.07 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -12.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -118.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -65.11 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -12,275.00 |
| Dec 31, 2018 | -12,275.00 |
| Sep 30, 2018 | 505.00 |
| Sep 30, 2018 | 505.00 |
| Mar 31, 2018 | 4,920.00 |
| Mar 31, 2018 | 4,920.00 |
| Dec 31, 2017 | 6,850.00 |
| Dec 31, 2017 | 6,850.00 |